Author:
Kopp Katherine O.,Glotfelty Elliot J.,Li Yazhou,Lahiri Debomoy K.,Greig Nigel H.
Funder
National Institutes of Health
National Institute on Aging
National Institute on Drug Abuse
Reference40 articles.
1. Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with parkinson disease: a secondaly analysis of the exenatide-PD Trial (vol 76, pg 420, 2019);Athauda;JAMA Neurol.,2019
2. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017
3. Exenatide and the treatment of patients with Parkinson's disease;Aviles-Olmos;J. Clin. Invest,2013
4. Neuroprotective effects and treatment potential of incretin mimetics in a murine model of mild traumatic brain injury;Bader;Front Cell Dev. Biol.,2020
5. Despite failing phase 2a clinical trials, Peptron not giving up on Parkinson’s treatment;Chang;Korea Biomed. Rev.,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献